Table 3 Dose to the ACT SMART Implementation Toolkit in aggregate and by individual agency implementation team
From: Fidelity to the ACT SMART Toolkit: an instrumental case study of implementation strategy fidelity
| Â | Aggregate Median | Agency 1 Median | Agency 2 Median | Agency 3a Median | Agency 4 Median | Agency 5 Median | Agency 6 Median |
|---|---|---|---|---|---|---|---|
Overall dose scores | 3.0 | 3.0 | 3.0 | 1.5 | 3.0 | 3.0 | 3.0 |
Phase 1: Exploration | †| †| †| †| †| †| †|
Phase 2: Adoption | 3.0 | 3.0 | 3.0 | 1.5 | 3.0 | 3.0 | 3.0 |
 Evaluate fit | 3.0 | 3 | 3 | 3 | 3 | 3 | 3 |
 Evaluate feasibility | 3.0 | 3 | 3 | 3 | 3 | 3 | 3 |
 Evaluate clinical utility and validity | 3.0 | 3 | 3 | 0 | 3 | 3 | 3 |
 Evaluate training requirements | 3.0 | * | 3 | * | 2 | * | 3 |
 Evaluate funding source | 3.0 | 3 | 1 | 3 | 3 | 3 | 1 |
 Evaluate benefits and costs | 1.0 | - | 3 | 0 | 0 | 3 | 1 |
 Validate adoption decision | 3.0 | 3 | 3 | 0a | 3 | 3 | 0 |
Phase 3: Preparation | 2.5 | 3.0 | 2.5 | Â | 2.5 | 0 | 2.0 |
 Gather and review treatment materials | 1.0 | 1 | 1 |  | 0 | 0 | 1 |
 Evaluate prospective adaptations | 3.0 | 3 | 3 |  | 3 | 0 | 3 |
 Develop adaptation plan | 1.5 | 3 | N/A |  | N/A | 0 | N/A |
 Develop training plan | 3.0 | 3 | 3 |  | 3 | 1 | 3 |
 Develop implementation plan | 2.0 | 1 | 2 |  | 2 | 3 | 0 |
Phase 4: Implementation b | 3.0 | 3.0 | 3.0 | Â | 3.0 | 3.0 | 3.0 |